FGEN vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 13, 2026

FGEN

43.2
AI Score
VS
FGEN Wins

CLYM

41.4
AI Score

Investment Advisor Scores

FGEN

43score
Recommendation
HOLD

CLYM

41score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric FGEN CLYM Winner
Forward P/E 61.3497 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 774.8% 0.0% FGEN
Earnings Growth 53.6% 0.0% FGEN
Tradestie Score 43.2/100 41.4/100 FGEN
Profit Margin 2598.9% 0.0% FGEN
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

FGEN 1M: +16.6% · 3M: -14.1% CLYM 1M: -1.0% · 3M: +30.6%

Current Technical Phase

FGEN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 59

RSI (14): 59.2 · Price: $9.71

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.8 · Price: $14.25

Fundamentals Snapshot

Metric FGEN CLYM
Market Cap
Forward P/E -0.8 -14.2
Trailing P/E
Revenue (TTM)
Revenue Growth 7.7% 0.0%
Gross Margin -3.7%
Operating Margin -5.0% 0.0%
EPS -12.85 -0.82
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, FGEN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.